Ani Pharmaceuticals (ANIP) Current Deferred Revenue (2012 - 2022)
Ani Pharmaceuticals (ANIP) posted Current Deferred Revenue of $116000.0 for Q1 2022, up 16.0% sequentially from $100000.0 in Q4 2021, and up 16.0% YoY from $100000.0 in Q1 2021.
Ani Pharmaceuticals (ANIP) Current Deferred Revenue (2012 - 2022) Analysis & Trends
Ani Pharmaceuticals has reported Current Deferred Revenue for 8 years, with the latest figure at $116000.0 in Q1 2022.
- Quarterly Current Deferred Revenue rose 16.0% year-over-year to $116000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $116000.0 (up 16.0% YoY) and the FY2021 annual result came in at $100000.0, up 25.0% from the prior year.
- Current Deferred Revenue improved to $116000.0 in Q1 2022 per ANIP's latest filing, from $100000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $735000.0 in Q3 2018 and troughed at $62000.0 in Q3 2021.
- A 5-year average of $315000.0 and a median of $125000.0 in 2020 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2020 and 2021: Current Deferred Revenue sank 84.0% in 2020, then increased 25.0% in 2021.
- Over 5 years, Current Deferred Revenue stood at $711000.0 in 2018, then fell by 29.68% to $500000.0 in 2019, then tumbled by 84.0% to $80000.0 in 2020, then climbed by 25.0% to $100000.0 in 2021, then gained by 16.0% to $116000.0 in 2022.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $116000.0, $100000.0, and $62000.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 116,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 80,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 125,000.00 |
| Mar 31, 2020 | 318,000.00 |
| Dec 31, 2019 | 500,000.00 |
| Sep 30, 2019 | 496,000.00 |
| Jun 30, 2019 | 558,000.00 |
| Mar 31, 2019 | 624,000.00 |
| Dec 31, 2018 | 711,000.00 |
| Sep 30, 2018 | 735,000.00 |
| Sep 30, 2014 | 20,000.00 |
| Jun 30, 2014 | 13,000.00 |
| Mar 31, 2014 | 38,000.00 |
| Dec 31, 2013 | 47,000.00 |
| Sep 30, 2013 | 46,712.00 |